Establishing CUX1 as a determinant of Hematopoietic Stem cell heterogeneity
建立 CUX1 作为造血干细胞异质性的决定因素
基本信息
- 批准号:10707891
- 负责人:
- 金额:$ 5.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-09-29
- 项目状态:未结题
- 来源:
- 关键词:AddressBindingBioinformaticsBiologicalBiologyBlood PlateletsC-terminalCatastrophic IllnessCationsCell CompartmentationCell CycleCell LineCell surfaceCellsChildhoodChromatinChromatin Remodeling FactorChromosomesClinicalCommunicationCuesCytoplasmDataDepositionDevelopmentDevelopmental BiologyDiagnosisDiseaseDoseDysplasiaEnhancersEquilibriumErythropoiesisEtiologyExhibitsFluorescenceGene ExpressionGenerationsGenesGenetic TranscriptionGenomicsGoalsHematologic NeoplasmsHematopoiesisHematopoieticHematopoietic NeoplasmsHematopoietic Stem Cell heterogeneityHematopoietic stem cellsHeterogeneityHomologous GeneHumanImmunophenotypingK562 CellsLinkLongevityLymphoidLymphopoiesisMapsMentorsMethodsModelingMolecularMultipotent Stem CellsMusMutationMyelogenousMyelopoiesisMyeloproliferative diseaseOrganismOutcomePatientsPerformancePhenotypePhysiciansPlayPopulationPropertyProteinsRecording of previous eventsRecurrenceRegulationReporterReportingReproducibilityRoleScientistSortingSystemTissuesTrainingTransplantationTumor Suppressor ProteinsUndifferentiatedVariantbody systemcell behaviordosageepigenomicsextracellulargene repressionhigh riskhomeodomainimproved outcomeinsightknock-downknowledgebasemolecular scalemouse modelnovel therapeuticsprospectiverecruitself-renewalskillsstem cell biologystem cellstranscription factortranscriptome
项目摘要
Project Summary/Abstract
Hematopoietic stem cells (HSCs) exhibit heterogeneity with respect to repopulating capacity, lineage bias,
and cell cycle participation. Teleologically, heterogeneity is the result of stem cells making fundamental
decisions regarding the population of the tissue. Differences in stem cell behavior have been linked to the
expression of cell surface and cytoplasmic markers without mechanistic explanation. HSC heterogeneity has
not previously been attributed to a transcription factor. We propose the observed heterogeneity in HSCs can
be explained by the actions of a dose-dependent, homeodomain-containing transcription factor, CUX1. Three
lines of evidence suggest CUX1 to be a putative orchestrator of HSC heterogeneity: it recurrently acts in a
dose-dependent manner across developmental systems, its recurrent loss in high-risk hematopoietic disease,
and its role in chromatin regulation.
I report the generation of a CUX1mCherry reporter mouse to study the role of CUX1 in hematopoiesis. The
Cux1mCherry mouse is the result of an in-frame, C-terminal mCherry tag at the endogenous CUX1 locus. The
addition of the tag creates no aberrant hematopoietic phenotype, suggesting this is a suitable model for the
proposed studies. The immunophenotypic long-term HSC (LT-HSC) compartment has among the greatest
variances in CUX1 expression. Across CUX1 protein levels in the LT-HSC compartment, we report several
correlations to strongly suggest that the observed variation in CUX1 protein results in meaningful differences in
stem cell behavior. For example, CUX1Bright HSCs are more likely to be cycling than CUX1Int and CUX1Dim
HSCs at steady state. Thus, our studies suggest that CUX1 is playing a dose-dependent role in murine
hematopoietic stem and progenitor cells (HSPCs). This proposal aims to (i) establish the role of CUX1 in
lineage bias and repopulating capacity and (ii) determine the mechanism by which CUX1 exerts a dose-
dependent role. Accomplishing the proposed studies will illuminate an important paradigm in developmental
biology: how a small pool of stem cells balance self-renewal and differentiation to give rise to all the mature
cells in a tissue. An etiological understanding of stem cell behavior will provide new insights into the
development of new therapies for the many diseases that arise in HSCs.
The project I propose here is accompanied by a training plan developed by me and my mentors that
delineates four goals I will need to accomplish to propel me towards becoming a successful independent
physician-scientist. These four goals include gaining expertise in hematopoiesis, gaining expertise in
bioinformatics, developing proficiency in scientific communication, and integrating the scientific and clinical
aspects of my training. Realizing these goals will give me the skills that I need to be a physician-scientist well-
equipped to address meaningful biological questions related to the catastrophic illnesses of childhood.
项目总结/摘要
造血干细胞(HSC)在再生能力、谱系偏好、
和细胞周期参与。从目的论上讲,异质性是干细胞使基本的
关于组织的群体的决定。干细胞行为的差异与
细胞表面和细胞质标记物的表达,而没有机制解释。HSC异质性
以前没有被归因于转录因子。我们认为观察到的HSC异质性可以
可以通过剂量依赖性、含有同源结构域的转录因子CUX1的作用来解释。三
一系列证据表明CUX1是HSC异质性的假定协调者:它在HSC异质性中反复起作用,
在发育系统中呈剂量依赖性,在高危造血系统疾病中反复丢失,
及其在染色质调节中的作用。
我报告了CUX1mCherry报告小鼠的产生,以研究CUX1在造血中的作用。的
Cux1mCherry小鼠是内源性CUX1基因座处的符合读框的C-末端mCherry标签的结果。的
标签的添加没有产生异常的造血表型,这表明这是一个合适的模型,
建议的研究。免疫表型长期HSC(LT-HSC)区室具有最大的
CUX1表达的差异。在LT-HSC区室的CUX1蛋白水平上,我们报告了几个
相关性强有力地表明,观察到的CUX1蛋白的变化导致了有意义的差异,
干细胞行为例如,CUX1Bright HSC比CUX1Int和CUX1Dim更可能循环
HSC处于稳态。因此,我们的研究表明,CUX1在小鼠中发挥剂量依赖性作用,
造血干细胞和祖细胞(HSPC)。该建议旨在(i)确立CUX 1在以下方面的作用:
谱系偏倚和再增殖能力,以及(ii)确定CUX1发挥剂量-
依赖角色。完成所提出的研究将阐明一个重要的范式,在发展
生物学:一小群干细胞如何平衡自我更新和分化,以产生所有成熟的干细胞。
组织中的细胞。对干细胞行为的病因学理解将为干细胞的生物学行为提供新的见解。
为HSC中出现的许多疾病开发新疗法。
我在这里提出的项目是伴随着我和我的导师开发的培训计划,
描述了四个目标,我需要完成,以推动我成为一个成功的独立
物理学家兼科学家这四个目标包括获得造血方面的专业知识,
生物信息学,发展科学交流能力,整合科学和临床
我的训练方面。实现这些目标将给我的技能,我需要成为一个医生,科学家以及-
有能力解决与儿童灾难性疾病有关的有意义的生物学问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tanner Clark Martinez其他文献
Tanner Clark Martinez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 5.27万 - 项目类别:
Discovery Projects